2022
Impact of Pre-Existing Ischemic Heart Disease on Severe Maternal Morbidity and Mortality During Delivery Hospitalizations
Denoble A, Goldstein S, Wein L, Grotegut C, Federspiel J. Impact of Pre-Existing Ischemic Heart Disease on Severe Maternal Morbidity and Mortality During Delivery Hospitalizations. JACC Advances 2022, 1: 100157. PMID: 36684662, PMCID: PMC9851052, DOI: 10.1016/j.jacadv.2022.100157.Peer-Reviewed Original ResearchSevere maternal morbidityIschemic heart diseaseDelivery hospitalizationsComplex survey methodsCardiac diseaseCardiac diagnosisMaternal morbidityHeart diseasePre-existing ischaemic heart diseasePre-existing ischemic heart diseaseNontransfusion severe maternal morbidityWorld Health Organization classificationClass IAdverse pregnancy outcomesNationwide Readmissions DatabaseRelative risk regressionWorld Health Organization class IPregnancy outcomesPrimary outcomeRetrospective studyAdverse outcomesUnadjusted analysesOrganization classificationRisk regressionWorse outcomes
2021
Socioeconomic disparities in surveillance and follow‐up of patients with thoracic aortic aneurysm
Shang M, Weininger G, Mori M, Kahler‐Quesada A, Degife E, Brooks C, Yousef S, Williams M, Assi R, Geirsson A, Vallabhajosyula P. Socioeconomic disparities in surveillance and follow‐up of patients with thoracic aortic aneurysm. Journal Of Cardiac Surgery 2021, 37: 831-839. PMID: 34873754, DOI: 10.1111/jocs.16173.Peer-Reviewed Original ResearchConceptsAortic aneurysmArea Deprivation IndexCardiovascular specialistsSocioeconomic statusSurgical interventionAneurysm sizeReferral of patientsRisk of deathSignificant risk factorsThoracic aortic aneurysmComputed tomography scanLowest socioeconomic quartileLow socioeconomic statusLower Socioeconomic StatusADI quartileAortic surveillanceAortic dissectionConsecutive patientsPrimary outcomeSpecialist referralSurgical repairTimely followSurveillance imagingRisk regressionRisk factorsIndividual and poly-substance use and condomless sex among HIV-uninfected adults reporting heterosexual sex in a multi-site cohort
Fredericksen RJ, Whitney BM, Trejo E, Nance RM, Fitzsimmons E, Altice FL, Carrico AW, Cleland CM, Del Rio C, Duerr A, El-Sadr WM, Kahana S, Kuo I, Mayer K, Mehta S, Ouellet LJ, Quan VM, Rich J, Seal DW, Springer S, Taxman F, Wechsberg W, Crane HM, Delaney JAC. Individual and poly-substance use and condomless sex among HIV-uninfected adults reporting heterosexual sex in a multi-site cohort. BMC Public Health 2021, 21: 2002. PMID: 34736425, PMCID: PMC8567631, DOI: 10.1186/s12889-021-12026-7.Peer-Reviewed Original ResearchConceptsLikelihood of CSRecent substance useHIV-negative partnersVaginal sexAnal sexSubstance useHIV-status unknown partnersMultivariable relative risk regressionExposure classificationType of sexHIV-negative adultsPooled effect estimatesPartner's HIV statusMulti-site cohortHigher likelihoodHeterosexual sexRelative risk regressionSingle substance usePoly-substance useHIV-negativeHIV statusRisk regressionPolysubstance useCannabis useSU exposureHigh Oxalate Concentrations Correlate with Increased Risk for Sudden Cardiac Death in Dialysis Patients
Pfau A, Ermer T, Coca S, Tio MC, Genser B, Reichel M, Finkelstein FO, März W, Wanner C, Waikar SS, Eckardt KU, Aronson P, Drechsler C, Knauf F. High Oxalate Concentrations Correlate with Increased Risk for Sudden Cardiac Death in Dialysis Patients. Journal Of The American Society Of Nephrology 2021, 32: 2375-2385. PMID: 34281958, PMCID: PMC8729829, DOI: 10.1681/asn.2020121793.Peer-Reviewed Original ResearchConceptsSudden cardiac deathCardiac deathCardiovascular eventsKidney failurePrimary composite cardiovascular end pointComposite cardiovascular end pointGerman Diabetes Dialysis StudyCox proportional hazards modelCardiovascular end pointsCohort of patientsNovel risk factorsProportional hazards modelCubic spline modelingCause mortalityChronic dialysisCardiovascular mortalityDialysis patientsStudy cohortUS patientsRisk regressionRisk factorsEuropean patientsSerum oxalate concentrationClinical significanceSeparate cohortInpatient Gastroenterology Consultation and Outcomes of Cirrhosis-Related Hospitalizations in Two Large National Cohorts
Serper M, Kaplan DE, Lin M, Taddei TH, Parikh ND, Werner RM, Tapper EB. Inpatient Gastroenterology Consultation and Outcomes of Cirrhosis-Related Hospitalizations in Two Large National Cohorts. Digestive Diseases And Sciences 2021, 67: 2094-2104. PMID: 34374917, PMCID: PMC10849043, DOI: 10.1007/s10620-021-07150-8.Peer-Reviewed Original ResearchConceptsLength of stayPropensity-matched analysisNational cohortSpecialty careHigher LOSAlcohol-associated hepatitisCirrhosis-related admissionsOutcome of cirrhosisSpontaneous bacterial peritonitisLarge national cohortCirrhosis complicationsHepatology consultationVA cohortIndex admissionGastroenterology consultationClinical characteristicsBacterial peritonitisLiver diseaseReadmission riskICD9/10 codesRisk regressionInpatient consultationsPatientsLower mortalityDisease severityDoes non‐invasive blood pressure measurement increase the complications and decrease indwelling time of peripheral intravenous catheters: A cohort study
Tan Q, Zhao S, Li X, Gu B, Ni Z. Does non‐invasive blood pressure measurement increase the complications and decrease indwelling time of peripheral intravenous catheters: A cohort study. Journal Of Clinical Nursing 2021, 30: 2287-2292. PMID: 33829602, DOI: 10.1111/jocn.15751.Peer-Reviewed Original ResearchConceptsPeripheral intravenous cathetersRenal transplant recipientsNon-invasive blood pressure measurementBlood pressure measurementsIntravenous cathetersRisk factorsControl groupTransplant recipientsCohort studyObservation groupNon-invasive blood pressure monitoringNon-invasive blood pressure monitorKidney recipient patientsIncidence of complicationsIndependent risk factorIncidence of phlebitisBlood pressure monitoringCox regression modelRelative risk factorsBlood pressure monitorPerioperative periodHigher BMIClinical complicationsRisk regressionRecipient patientsPredicting toxicity-related docetaxel discontinuation and overall survival in metastatic castration-resistant prostate cancer: a pooled analysis of open phase 3 clinical trial data
Martini A, Parikh A, Sfakianos J, Montorsi F, Galsky M, Oh W, Tsao C. Predicting toxicity-related docetaxel discontinuation and overall survival in metastatic castration-resistant prostate cancer: a pooled analysis of open phase 3 clinical trial data. Prostate Cancer And Prostatic Diseases 2021, 24: 743-749. PMID: 33531652, DOI: 10.1038/s41391-021-00326-3.Peer-Reviewed Original ResearchConceptsMetastatic castration-resistant prostate cancerCastration-resistant prostate cancerRisk groupsDocetaxel discontinuationDocetaxel toxicityProstate cancerPhase 3 clinical trial dataCurrent treatment landscapeECOG performance statusPresence of diabetesChronic kidney diseaseIndividual patient dataProject Data SphereMedian OSOverall survivalTreatment landscapePerformance statusPooled analysisRisk regressionPrimary outcomeKidney diseaseTreatment selectionDocetaxelControl armInclusion criteria
2020
Predicting toxicity-related docetaxel discontinuation and survival in metastatic castration-resistant prostate cancer (mCRPC) using open phase III trial data.
Parikh A, Martini A, Sfakianos J, Galsky M, Oh W, Tsao C. Predicting toxicity-related docetaxel discontinuation and survival in metastatic castration-resistant prostate cancer (mCRPC) using open phase III trial data. Journal Of Clinical Oncology 2020, 38: 75-75. DOI: 10.1200/jco.2020.38.6_suppl.75.Peer-Reviewed Original ResearchMetastatic castration-resistant prostate cancerRisk groupsMedian OSOverall survivalCumulative incidenceKaplan-MeierCastration-resistant prostate cancerPhase III trial dataControl armMedian Follow-UpECOG performance statusKaplan-Meier (KM) methodChronic kidney diseaseRisk calculatorProject Data SphereD′′ discontinuityDiagnosis of diabetesDocetaxel discontinuationDemographic/clinical dataPerformance statusProstate cancerPooled patientsFollow-upRisk regressionPrimary outcome
2017
Racial disparities in prostate cancer outcome among prostate-specific antigen screening eligible populations in the United States
Mahal B, Chen Y, Muralidhar V, Mahal A, Choueiri T, Hoffman K, Hu J, Sweeney C, Yu J, Feng F, Kim S, Beard C, Martin N, Trinh Q, Nguyen P. Racial disparities in prostate cancer outcome among prostate-specific antigen screening eligible populations in the United States. Annals Of Oncology 2017, 28: 1098-1104. PMID: 28453693, DOI: 10.1093/annonc/mdx041.Peer-Reviewed Original ResearchConceptsProstate cancer-specific mortalityProstate-specific antigenUnited States Preventive Services Task ForceRisk of prostate cancer-specific mortalityProstate cancer outcomesBlack raceMetastatic diseaseCancer outcomesProstate-specific antigen screeningRate of metastatic diseasePSA screening guidelinesCancer-specific mortalityRisk of poor outcomesStage of presentationPreventive Services Task ForceScreening-eligible ageMultivariate logistic regressionEligible populationNon-black menSEER databaseProstate cancerBlack menScreening guidelinesPoor outcomeRisk regressionRacial disparities in prostate cancer outcome among prostate-specific antigen screening eligible populations in the United States.
Mahal B, Chen Y, Muralidhar V, Mahal A, Choueiri T, Hoffman K, Hu J, Sweeney C, Beard C, Martin N, Feng F, Kim S, Yu J, Trinh Q, Nguyen P. Racial disparities in prostate cancer outcome among prostate-specific antigen screening eligible populations in the United States. Journal Of Clinical Oncology 2017, 35: 18-18. DOI: 10.1200/jco.2017.35.6_suppl.18.Peer-Reviewed Original ResearchProstate cancer-specific mortalityProstate-specific antigenRisk of prostate cancer-specific mortalityProstate-specific antigen screeningProstate cancer outcomesUnited States Preventive Services Task ForceBlack raceMetastatic diseaseCancer outcomesRate of metastatic diseaseCancer-specific mortalityStage of presentationRisk of poor outcomesPreventive Services Task ForceScreening-eligible ageMultivariate logistic regressionEligible populationNon-black menProstate-specificSEER databaseProstate cancerBlack menPoor outcomeRisk regressionBlack patients
2015
The differential associations of preexisting conditions with trauma-related outcomes in the presence of competing risks
Calvo R, Lindsay S, Edland S, Macera C, Wingard D, Ohno-Machado L, Sise M. The differential associations of preexisting conditions with trauma-related outcomes in the presence of competing risks. Injury 2015, 47: 677-684. PMID: 26684173, DOI: 10.1016/j.injury.2015.10.055.Peer-Reviewed Original ResearchConceptsPre-existing chronic conditionsOlder trauma patientsHospital mortalityTrauma patientsMortality riskHigh-risk groupLow-risk subgroupsLower mortality riskLonger HLOSHospital lengthMost patientsRisk patientsClinical outcomesLiver diseaseRetrospective studyTrauma populationTrauma-related outcomesRisk regressionChronic conditionsExcess mortalityParkinson's diseaseLevel ICare facilitiesPatientsClinical decision
2014
STI Diagnosis and HIV Testing Among OEF/OIF/OND Veterans
Goulet JL, Martinello RA, Bathulapalli H, Higgins D, Driscoll MA, Brandt CA, Womack JA. STI Diagnosis and HIV Testing Among OEF/OIF/OND Veterans. Medical Care 2014, 52: 1064-1067. PMID: 25334054, PMCID: PMC4232995, DOI: 10.1097/mlr.0000000000000253.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusHIV testing ratesSTI diagnosisHIV testingTesting ratesPatient characteristicsHigher HIV testing ratesPrevious HIV test resultsVeterans Health Administration (VHA) servicesRoutine HIV testingVHA administrative dataHIV test resultsRelative risk regressionSubstance abuse disordersPositive test resultsOEF/OIF/OND veteransPosttraumatic stress disorderHIV testImmunodeficiency virusRisk regressionInfection diagnosisMAIN OUTCOMEAbuse disordersService veteransOlder age
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply